Trelegy ellipta 100-62.5-25 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F7VL2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $85,546
Award facts
- Contract value 100% obligated
- $85,546.43 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $85.5K delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. The contract is a firm fixed-price delivery order with an ultimate completion date of January 29, 2026, and was awarded on January 28, 2026 without set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the operating subsidiary of parent company Cencora, Inc., and serves as a critical pharmaceutical distributor for federal medical procurement.
This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026, which provides comprehensive pharmaceutical and medical supply support to military healthcare systems globally. The IDC encompasses specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains, enabling AmerisourceBergen to supply the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company competes on a full and open basis for these contracts, demonstrating its capability to meet federal procurement requirements across diverse medical product categories.
Quick answers
Who was awarded contract SPE2DR26F7VL2?
SPE2DR26F7VL2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26F7VL2 worth?
The government has obligated $85,546 on SPE2DR26F7VL2.
Is contract SPE2DR26F7VL2 an order under another contract?
Yes. SPE2DR26F7VL2 is a delivery order under SPE2DR25D2216, an indefinite delivery contract.
Was contract SPE2DR26F7VL2 competed?
The extent of competition for SPE2DR26F7VL2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award